Radiolabeled quinazoline derivatives
US-2015368230-A1 · Dec 24, 2015 · US
US9610369B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9610369-B2 |
| Application number | US-201414781994-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 2, 2014 |
| Priority date | Apr 5, 2013 |
| Publication date | Apr 4, 2017 |
| Grant date | Apr 4, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a compound represented by formula (I), wherein in formula (I), R 1 represents CH 3 , F, (CH 2 ) n —F, NH—(CH 2 ) n —F, O—(CH 2 ) n —F or S—(CH 2 ) n —F, and n represents an integer of 1 to 3.
Opening claim text (preview).
The invention claimed is: 1. A compound represented by formula (I): wherein in formula (I), R 1 represents CH 3 , F, (CH 2 ) n —F, NH—(CH 2 ) n —F, O—(CH 2 ) n or S—(CH 2 ) n —F, and n represents an integer of 1 to 3. 2. The compound according to claim 1 , wherein R 1 is 11 CH 3 , 18 F, (CH 2 ) n — 18 F, —(CH 2 ) n — 18 F, O—(CH 2 ) n — 18 F or S—(CH 2 ) n — 18 F, and n represents an integer of 1 to 3. 3. The compound according to claim 1 , represented by any one of formulas (II) to (V): 4. The compound according to claim 3 , wherein CH 3 is 11 CH 3 . 5. A compound represented by formula (VI): wherein in formula (VI), R 2 represents OH, SH, or an organic group containing B. 6. A vesicular acetylcholine transporter detection reagent, containing a compound according to claim 1 . 7. A diagnostic agent for Alzheimer's disease, containing a compound according to claim 1 . 8. The vesicular acetylcholine transporter detection reagent according to claim 6 , wherein the compound is a compound represented by either one of formulas (IV) and (V): 9. The diagnostic agent for Alzheimer's disease according to claim 7 , wherein the compound is a compound represented by either one of formulas (IV) and (V): 10. A vesicular acetylcholine transporter detection reagent, containing a compound according to claim 2 . 11. A vesicular acetylcholine transporter detection reagent, containing a compound according to claim 3 . 12. A vesicular acetylcholine transporter detection reagent, containing a compound according to claim 4 . 13. A diagnostic agent for Alzheimer's disease, containing a compound according to claim 2 . 14. A diagnostic agent for Alzheimer's disease, containing a compound according to claim 3 . 15. A diagnostic agent for Alzheimer's disease, containing a compound according to claim 4 .
Heterocyclic compounds · CPC title
with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings · CPC title
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.